Results 181 to 190 of about 691,015 (282)

Imagery rescripting for generalized anxiety disorder: A case series

open access: yesBritish Journal of Clinical Psychology, EarlyView.
Abstract Introduction This is the first clinical pilot to explore the feasibility, acceptability and preliminary efficacy of imagery rescripting in individuals with a diagnosis of generalized anxiety disorder (GAD). Methods Participants with GAD (N = 18) attended assessment and 10 weekly sessions of imagery rescripting with a psychologist in person or ...
L. Stavropoulos   +6 more
wiley   +1 more source

Beyond symptom reduction: The longitudinal relationship between eating disorder symptoms and mental wellbeing in young women

open access: yesBritish Journal of Clinical Psychology, EarlyView.
Abstract Background Eating disorder (ED) symptoms and mental wellbeing are related but distinct dimensions of mental health. However, little is known about their longitudinal relationship, which is essential for understanding prevention and intervention targets. This study examined temporal relationships between ED symptoms and mental wellbeing over 12 
Katharine Scutt   +3 more
wiley   +1 more source

Mosapride versus Metoclopramide in Critically Ill Patients with Enteral Feeding Intolerance: A Randomized, Double-Blinded Comparison. [PDF]

open access: yesDrug Des Devel Ther
Mohamed Elmokadem E   +4 more
europepmc   +1 more source

Investigating the events that predispose vulnerable and feared self‐concepts in obsessive‐compulsive disorder: A qualitative analysis

open access: yesBritish Journal of Clinical Psychology, EarlyView.
Abstract Objectives The feared self‐concept, the self that a person fears they may be or could become, has been increasingly shown to drive the development and maintenance of obsessive‐compulsive disorder (OCD). It is proposed that the feared self develops from a vulnerable self‐concept, which itself is a result of normative self‐concept development ...
I. Gomez   +4 more
wiley   +1 more source

Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real‐world evidence

open access: yesBritish Journal of Haematology, EarlyView.
Summary Ruxolitinib remains first‐line standard of care for symptomatic myelofibrosis, but resistance/intolerance develops in most patients. Three Janus kinase inhibitors (JAKis) have entered the post‐ruxolitinib space via distinct pivotal trials. We systematically searched prospective trials evaluating JAKi in refractory adults with myelofibrosis ...
Andrea Duminuco   +8 more
wiley   +1 more source

A comprehensive review of cancer‐induced cardiac wasting

open access: yesBritish Journal of Pharmacology, EarlyView.
Cancer is frequently accompanied by cachexia, a systemic syndrome characterized by progressive loss of skeletal muscle mass, with or without loss of fat mass. Increasing evidence indicates that cancer can also induce cardiac muscle wasting, which is associated with structural cardiac remodelling, impaired contractile function and the development of ...
Alessia Lena   +5 more
wiley   +1 more source

Gut microbiota as a novel therapeutic target for eating disorders and obesity

open access: yesBritish Journal of Pharmacology, EarlyView.
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy